CIPO Patents = 1

EPO Patents = 1

Forward Citations = 159

Loading Chart...

5 inventors (with patents filed for the assignee):

Alain D Baron (13 out of 32 patents)

Mark S Fineman (13 out of 27 patents)

Nigel R A Beeley (13 out of 24 patents)

4. Martin R Brown (1 out of 5 patents)

5. Christopher R G Jones (1 out of 4 patents)

6. Christopher R Jones (0 patent)

7. Christopher RG Jones (0 patent)

13 patents: Sort by Forward Citations

1. 10201511 - Compositions and methods for treating metabolic disorders (2019-02-12),

2. 10159658 - Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk (2018-12-25),

3. 10154972 - Biguanide compositions and methods of treating metabolic disorders (2018-12-18),

4. 10028923 - Biguanide compositions and methods of treating metabolic disorders (2018-07-24),

5. 9962344 - Chemosensory receptor ligand-based therapies (2018-05-08),

6. 9770422 - Compositions and methods for treating metabolic disorders (2017-09-26),

7. 9572784 - Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk (2017-02-21),

8. 9481642 - Biguanide compositions and methods of treating metabolic disorders (2016-11-01),

9. 9480663 - Biguanide compositions and methods of treating metabolic disorders (2016-11-01),

10. 9463170 - Chemosensory receptor ligand-based therapies (2016-10-11),

11. 9211263 - Compositions and methods of treating metabolic disorders (2015-12-15),

12. 9050292 - Chemosensory receptor ligand-based therapies (2015-06-09),

13. 8796338 - Biguanide compositions and methods of treating metabolic disorders (2014-08-05),

Company Overview

Elcelyx Therapeutics, Inc. is a biotechnology company based in San Diego, California, focused on developing innovative therapies for metabolic diseases. The company specializes in creating novel treatments that target conditions such as diabetes and obesity, leveraging advanced drug delivery technologies and proprietary formulations. Elcelyx aims to improve patient outcomes through its commitment to research and development in the field of metabolic health, striving to address significant unmet medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

13 Patents

#411 in San Diego, CA

#5,656 in California

#23,838 in US

#45,039 in the World

San Diego, CA, United States of America

Elcelyx Therapeutics, Inc.

Forward Citations = 159

5 inventors:

Alain D Baron (13 out of 32 patents)

Mark S Fineman (13 out of 27 patents)

Nigel R A Beeley (13 out of 24 patents)

4. Martin R Brown (1 out of 5 patents)

5. Christopher R G Jones (1 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Elcelyx Therapeutics, Inc.. Retrieved from https://idiyas.com/company/elcelyx-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]